trending Market Intelligence /marketintelligence/en/news-insights/trending/WKlG9J3v2nZDMGreIJsZng2 content esgSubNav
In This List

Syros Pharmaceuticals appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Syros Pharmaceuticals appoints director

Syros Pharmaceuticals Inc. appointed Srinivas Akkaraju to the company's board of directors.

Akkaraju is a founder and managing general partner at Samsara BioCapital and currently serves as chairman of Versartis Inc.